Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis.
- 2024-07
- RCT · n = 50
- Hipertension y riesgo vascular 41(3)
- R L Sanz
- F García
- A Gutierrez
- S García Menendez
- F Inserra
- L Ferder
- W Manucha
- PubMed: 38871574
- DOI: 10.1016/j.hipert.2024.04.002
- High evidence
- Clinical
The Ang-(1-7)/Ang II ratio, as an indirect measure of ACE2 enzymatic activity, increased in the vitamin D3 group (24±5pg/mL vs. 4.66±2pg/mL, p<0.01).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- 10,000 IU/day